Back to search

Article

Design, synthesis, and biological evaluation of 1,8-naphthyridine derivatives as RSK4 inhibitors for the treatment of lung cancer

2018-01-01

Abstract excerpt

Lung cancer is the most common cause of cancer death worldwide and it has one of the lowest survival rates among tumours, thus the need to develop new drugs to treat the disease is clear. Among the different kinases involved in cancer pathologies in general, and in lung cancer, we focused our efforts on the validation of RSK4 as a tumour promoter in the lungs. Preliminary unpublished results suggested the antibiot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d7bcd90c-255b-52ca-9905-051238104cfc
DOI
10.25560/84677
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Design, synthesis, and biological evaluation of 1,8-naphthyridine derivatives as RSK4 inhibitors for the treatment of lung cancerDOI 10.25560/84677
Select a neighboring publication to make it the new centre.